Oculis Holding
OCS
9 hedge funds and large institutions have $32.1M invested in Oculis Holding in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.61% less ownership
Funds ownership: 8.63% → 8.02% (-0.61%)
90% less capital inflows, than outflows
Capital inflows: $277K | Capital outflows: $2.89M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$161K |
| 2 |
Wolverine Asset Management
Chicago,
Illinois
|
+$88.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$25.1K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$2.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$2.04M |
| 2 |
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$557K |
| 3 |
E
Ergoteles
New York
|
-$247K |
| 4 |
Barclays
London,
United Kingdom
|
-$44.4K |
OCS Hedge Fund Activity: Q3 2023 in Review
9 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Oculis Holding (OCS) for Q3 2023, worth a combined $32.1M — down 17% from $38.5M a quarter earlier.
Fund positioning in OCS was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, adding an estimated $161K. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $2.04M.
- 9 institutional investors held Oculis Holding (OCS) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $32.1M of Oculis Holding stock for Q3 2023, down 17% quarter-over-quarter.
- 2 funds opened new Oculis Holding positions in Q3 2023 and 2 closed out, a net change of 0 holders.
- The largest Oculis Holding buyer in Q3 2023 was Bank of America, an estimated $161K added.
- The largest Oculis Holding seller in Q3 2023 was Pivotal bioVenture Partners Investment Advisor, an estimated $2.04M sold.
Based on aggregated 13F filings for Q3 2023.